Background
Mme [J] [R], an employee of company [1], applied in April 2018 for recognition of left cervicobrachial neuralgia as an occupational disease. Because that condition was not listed in an official occupational-disease table, recognition under the supplementary system required both proof that the disease was essentially and directly caused by her usual work and a permanent-disability rate of at least 25%.
The local primary health-insurance fund declined to submit her claim for examination under that system because its medical-control service assessed her anticipated permanent-disability rate at less than 25%. She challenged the refusal, but the Rouen Court of Appeal rejected her claim. On appeal to the Court of Cassation, she argued principally that the threshold created unjustified discrimination contrary to Article 14 of the European Convention on Human Rights, read with Article 1 of Protocol No. 1.
The Court’s Holding
The Court of Cassation dismissed the appeal. It held that, for a disease not appearing in an occupational-disease table, the relevant disability rate is the “anticipated rate” assessed by the medical-control service for the file prepared for referral to the regional occupational-disease recognition committee. If that rate is below 25%, the disease cannot be recognized as occupational under the applicable version of Articles L. 461-1 and R. 461-8 of the Social Security Code.
The Court found that claimants with unlisted diseases are not comparably situated to those with listed diseases, because listed diseases are scientifically recognized as potentially occupational in origin. It did find that people with different disability levels but the same kind of unlisted disease are comparably situated and that the 25% threshold therefore creates differential treatment. That distinction was nevertheless objectively and reasonably justified: it serves the legitimate public-interest goal of maintaining the funding and financial balance of an employer-funded compensation scheme, relies on the objective criterion of potential disease severity, and does not leave below-threshold claimants wholly without protection because the general health-insurance branch covers part of their losses.
The Court added that neither domestic law nor the Convention gives an employee with an unlisted disease an unconditional right to have its occupational origin determined in every case. It therefore upheld the appellate court’s ruling; the claimant’s remaining ground was rejected without a specially reasoned decision because it was manifestly incapable of supporting cassation.
Key Takeaways
- An unlisted disease cannot qualify for occupational-disease recognition under the supplementary system when the medically assessed anticipated permanent-disability rate is below 25%.
- Although the threshold treats claimants with unlisted diseases differently according to disability severity, the Court held that the distinction is proportionate to the legitimate goal of preserving the employer-funded scheme’s financial balance.
- Workers with listed diseases are not a valid comparator because those diseases already have scientifically recognized potential links to occupational exposure.
Why It Matters
The decision confirms that the 25% anticipated-disability threshold is a substantive gateway to recognition, not merely a procedural condition for referral to a regional committee. A claimant with an unlisted disease cannot require the committee to examine occupational causation when the anticipated rate falls below that threshold.
The ruling also supplies a Convention-based justification for severity thresholds in French social-insurance legislation, emphasizing the state’s broad discretion in structuring social-security benefits and balancing access to occupational-risk compensation against the scheme’s financing constraints.